GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apellis Pharmaceuticals Inc (STU:1JK) » Definitions » Inventories, Raw Materials & Components

Apellis Pharmaceuticals (STU:1JK) Inventories, Raw Materials & Components : €0.0 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Apellis Pharmaceuticals Inventories, Raw Materials & Components?

Apellis Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Sep. 2024 was €0.0 Mil.

Apellis Pharmaceuticals's quarterly raw materials declined from Mar. 2024 (€38.7 Mil) to Jun. 2024 (€0.0 Mil) but then stayed the same from Jun. 2024 (€0.0 Mil) to Sep. 2024 (€0.0 Mil).

Apellis Pharmaceuticals's annual raw materials increased from Dec. 2021 (€5.1 Mil) to Dec. 2022 (€28.2 Mil) and increased from Dec. 2022 (€28.2 Mil) to Dec. 2023 (€30.0 Mil).


Apellis Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Apellis Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apellis Pharmaceuticals Inventories, Raw Materials & Components Chart

Apellis Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 5.09 28.18 30.01

Apellis Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.50 30.01 38.72 - -

Apellis Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Apellis Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
100 Fifth Avenue, Waltham, MA, USA, 02451
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Apellis Pharmaceuticals Headlines

No Headlines